GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
267 hedge funds and large institutions have $2.51B invested in Genomic Health, Inc. in 2019 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 104 increasing their positions, 70 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
267
Holders Change
+39
Holders Change %
+17.11%
% of All Funds
5.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
60
Increased
104
Reduced
70
Closed
21
Calls
$4.39M
Puts
$5.3M
Net Calls
-$911K
Net Calls Change
+$329K
Top Buyers
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
$714M |
| 2 |
D.E. Shaw & Co
New York
|
$11.9M |
| 3 |
Citigroup
New York
|
$1.57M |
| 4 |
Millennium Management
New York
|
$38.9M |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
$2.45M |